1 |
Ahn HS, Kim HJ, Welch HG. Korea′s thyroid-cancer ″epidemic″-screening and overdiagnosis [J]. N Engl J Med, 2014, 371(19): 1765-1767.
|
2 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
3 |
Hedinger C. Histological Typing of Thyroid Tumours [M]// Histological typing of thyroid tumours. Springer-Verlag, 1988: 513.
|
4 |
Lim H, Devesa SS, Sosa JA, et al. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 [J]. JAMA, 2017, 317(13): 1338-1348.
|
5 |
Vaccarella S, Franceschi S, Bray F, et al. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis [J]. N Engl J Med, 2016, 375(7): 614-617.
|
6 |
Leboulleux S, Tuttle RM, Pacini F, et al. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? [J]. Lancet Diabetes Endocrinol, 2016, 4(11): 933-942.
|
7 |
McLeod DS, Sawka AM, Cooper DS. Controversies in primary treatment of low-risk papillary thyroid cancer [J]. Lancet, 2013, 381(9871): 1046-1057.
|
8 |
National Comprehensive Cancer Network. Thyroid Carcinoma [EB/OL]. [2018-10-22].
URL
|
9 |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J]. Thyroid , 2016, 26(1): 1-133.
|
10 |
Yue W, Wang S, Yu S, et al. Ultrasound-guided percutaneous microwave ablation of solitary T1N0M0 papillary thyroid microcarcinoma: initial experience [J]. Int J Hyperthermia, 2014, 30(2): 150-157.
|
11 |
Lee CU, Kim SJ, Sung JY, et al. Needle track tumor seeding after radiofrequency ablation of a thyroid tumor [J]. Jpn J Radiol, 2014, 32(11): 661-663.
|
12 |
Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound guided radiofrequency ablation for treating low risk papillary thyroid microcarcinoma: a prospective study [J]. Thyroid, 2016, 26(11): 1581-1587.
|
13 |
Li J, Liu Y, Liu J, et al. Ultrasound-guided percutaneous microwave ablation versus surgery for papillary thyroid microcarcinoma [J]. Int J Hyperthermia, 2018, 34(5): 653-659.
|
14 |
Zhang L, Zhou W, Zhan W, et al. Percutaneous Laser Ablation of Unifocal Papillary Thyroid Microcarcinoma: Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Assessing Local Therapeutic Response [J]. World J Surg, 2018, 42(8): 2476-2484.
|
15 |
Jeong SY, Baek JH, Choi YJ, et al. Radiofrequency Ablation of Primary Thyroid Carcinoma: Efficacy According to the Types of Thyroid Carcinoma [J]. Int J Hyperthermia, 2018, 34(5): 611-616.
|
16 |
Teng D, Sui G, Liu C, et al. Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study [J]. J Cancer Res Clin Oncol, 2018, 144(4): 771-779.
|
17 |
Zhou W, Jiang S, Zhan W, et al. Ultrasound-guided percutaneous laser ablation of unifocal T1N0M0 papillary thyroid microcarcinoma: Preliminary results [J]. Eur Radiol, 2017, 27(7): 2934-2940.
|
18 |
Valcavi R, Piana S, Bortolan GS, et al. Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation [J]. Thyroid, 2013, 23(12): 1578-1582.
|
19 |
Papini E, Guglielmi R, Gharib H, et al. Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk [J]. Thyroid, 2011, 21(8): 917-920.
|
20 |
高明, 葛明华, 嵇庆海, 等. 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版) [J]. 中国肿瘤临床, 2016, 43(12): 526-526.
|
21 |
葛明华, 徐栋, 杨安奎, 等. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗专家共识(2018版) [J].中国肿瘤, 2018, 27(10): 768-773.
|
22 |
Haymart MR, Miller DC, Hawley ST, et al. Active Surveillance for Low-Risk Cancers-A Viable Solution to Overtreatment? [J]. N Engl J Med, 2017, 377(3): 203-206.
|
23 |
Vanderlaan WP. The occurrence of carcinoma of the thyroid gland in autopsy material [J]. N Engl J Med, 1947, 237(7): 221.
|
24 |
Yu XM, Wan Y, Sippel RS, et al. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases [J]. Ann Surg, 2011, 254(4): 653-660.
|
25 |
Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4): 381-387.
|
26 |
Ito Y, Miyauchi A, Kihara M, et al. Patient Age is Significantly Related to the Progression of Papillary Microcarcinoma of the Thyroid Under Observation [J]. Thyroid, 2014, 24(1): 27-34.
|
27 |
Ito Y, Miyauchi A, Inoue H, et al. An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients [J]. World J Surg, 2010, 34(1): 28-35.
|
28 |
Sugitani I, Toda K, Yamada K, et al. Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and Outcomes [J]. World J Surg, 2010, 34(6): 1222-1231.
|
29 |
The Japanese Society of Thyroid Surgery/The Japanese Society of endocrine Surgeons. Guidelines for management of thyroid tumor [M]. Tokyo: Kanehara Press, 2010.
|
30 |
Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cance [J]. Thyroid, 2009, 19(11): 1167-1214.
|
31 |
Oda H, Miyauchi A, Ito Y, et al. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery [J]. Thyroid, 2016, 26(1): 150-155.
|
32 |
Oda H, Miyauchi A, Ito Y, et al. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid [J]. Endocr J, 2017, 64(1): 59-64.
|
33 |
Ito Y, Miyauchi A, Kudo T, et al. Trends in the Implementation of Active Surveillance for Low-Risk Papillary Thyroid Microcarcinomas at Kuma Hospital: Gradual Increase and Heterogeneity in the Acceptance of this New Management Option [J]. Thyroid, 2018, 28(4): 488-495.
|
34 |
Haser GC, Tuttle RM, Urken ML. Challenges of Active Surveillance Protocols for Low Risk Papillary Thyroid Microcarcinoma in the United States [J]. Thyroid, 2016, 26(7): 989-990.
|
35 |
Nickel B, Brito JP, Barratt A, et al. Clinicians′ Views on Management and Terminology for Papillary Thyroid Microcarcinoma: a Qualitative Study [J]. Thyroid, 2017, 27(5): 661-671.
|
36 |
Nickel B, Brito JP, Moynihan R, et al. Patients′ experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study [J]. BMC Cancer, 2018, 18(1): 242.
|
37 |
Garberoglio R, Aliberti C, Appetecchia M, et al. Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement [J]. J Ultrasound, 2015, 18(4): 423-430.
|
38 |
Na DG, Lee JH, Jung SL, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations [J]. Korean J Radiol, 2012, 13(2): 117-125.
|
39 |
Dupuy DE, Monchik JM, Decrea C, et al. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy [J] surgery, 2002, 130(6): 971-977.
|
40 |
Ma B, Wei W, Xu W, et al. Surgical Confirmation of Incomplete Treatment for Primary Papillary Thyroid Carcinoma by Percutaneous Thermal Ablation: a Retrospective Case Review and Literature Review [J]. Thyroid, 2018, 28(9): 1134-1142.
|
41 |
董文武, 张浩, 张平, 等. 甲状腺乳头状癌射频消融治疗后再手术5例临床分析 [J]. 中国实用外科杂志, 2015, 35(6): 653-655.
|